nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2D6—Carteolol—glaucoma	0.082	0.123	CbGbCtD
Rimonabant—CYP1A2—Betaxolol—glaucoma	0.0672	0.101	CbGbCtD
Rimonabant—CYP2D6—Betaxolol—glaucoma	0.0554	0.0829	CbGbCtD
Rimonabant—CYP2C9—Diclofenamide—glaucoma	0.0533	0.0798	CbGbCtD
Rimonabant—CYP2C9—Dorzolamide—glaucoma	0.0515	0.0771	CbGbCtD
Rimonabant—CYP2C9—Methazolamide—glaucoma	0.0459	0.0687	CbGbCtD
Rimonabant—CYP2D6—Methazolamide—glaucoma	0.042	0.0628	CbGbCtD
Rimonabant—CYP3A4—Pilocarpine—glaucoma	0.0395	0.0592	CbGbCtD
Rimonabant—CYP1A2—Clonidine—glaucoma	0.0368	0.0551	CbGbCtD
Rimonabant—CYP2D6—Timolol—glaucoma	0.0357	0.0534	CbGbCtD
Rimonabant—CYP3A4—Brinzolamide—glaucoma	0.031	0.0464	CbGbCtD
Rimonabant—CYP2D6—Clonidine—glaucoma	0.0303	0.0454	CbGbCtD
Rimonabant—CYP3A4—Dorzolamide—glaucoma	0.0299	0.0448	CbGbCtD
Rimonabant—CYP3A4—Methazolamide—glaucoma	0.0267	0.04	CbGbCtD
Rimonabant—CYP3A4—Acetazolamide—glaucoma	0.0213	0.0319	CbGbCtD
Rimonabant—CYP3A4—Clonidine—glaucoma	0.0193	0.0289	CbGbCtD
Rimonabant—CNR2—Small Ligand GPCRs—PTGFR—glaucoma	0.0105	0.134	CbGpPWpGaD
Rimonabant—CNR1—Small Ligand GPCRs—PTGFR—glaucoma	0.0082	0.106	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—PTGFR—glaucoma	0.00234	0.0301	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00157	0.0203	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00144	0.0185	CbGpPWpGaD
Rimonabant—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00135	0.0174	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.0013	0.0167	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00124	0.0159	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00123	0.0159	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—NCK2—glaucoma	0.00123	0.0158	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—SMO—glaucoma	0.00118	0.0152	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00113	0.0145	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00111	0.0143	CbGpPWpGaD
Rimonabant—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00109	0.014	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00102	0.0131	CbGpPWpGaD
Rimonabant—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00099	0.0127	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000968	0.0125	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—OPN4—glaucoma	0.00094	0.0121	CbGpPWpGaD
Rimonabant—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00093	0.012	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000872	0.0112	CbGpPWpGaD
Rimonabant—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000846	0.0109	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—PTGFR—glaucoma	0.000846	0.0109	CbGpPWpGaD
Rimonabant—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000827	0.0106	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—NTRK2—glaucoma	0.000748	0.00963	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—OPN4—glaucoma	0.000737	0.00949	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—PTGFR—glaucoma	0.000664	0.00854	CbGpPWpGaD
Rimonabant—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000653	0.0084	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—NGFR—glaucoma	0.000642	0.00826	CbGpPWpGaD
Rimonabant—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000638	0.00822	CbGpPWpGaD
Rimonabant—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000631	0.00811	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—NTRK1—glaucoma	0.00061	0.00785	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—BDNF—glaucoma	0.000559	0.00719	CbGpPWpGaD
Rimonabant—Tremor—Pilocarpine—glaucoma	0.000554	0.00218	CcSEcCtD
Rimonabant—Pruritus—Latanoprost—glaucoma	0.000552	0.00217	CcSEcCtD
Rimonabant—Rash—Diclofenamide—glaucoma	0.000552	0.00217	CcSEcCtD
Rimonabant—Diarrhoea—Methazolamide—glaucoma	0.000551	0.00217	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Betaxolol—glaucoma	0.000549	0.00216	CcSEcCtD
Rimonabant—Headache—Diclofenamide—glaucoma	0.000548	0.00215	CcSEcCtD
Rimonabant—Insomnia—Bimatoprost—glaucoma	0.000547	0.00215	CcSEcCtD
Rimonabant—Dry mouth—Brimonidine—glaucoma	0.000546	0.00215	CcSEcCtD
Rimonabant—Vomiting—Carbachol—glaucoma	0.000543	0.00213	CcSEcCtD
Rimonabant—Hallucination—Clonidine—glaucoma	0.00054	0.00212	CcSEcCtD
Rimonabant—Hypoaesthesia—Clonidine—glaucoma	0.00054	0.00212	CcSEcCtD
Rimonabant—Rash—Carbachol—glaucoma	0.000538	0.00212	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000538	0.00212	CcSEcCtD
Rimonabant—Dermatitis—Carbachol—glaucoma	0.000538	0.00211	CcSEcCtD
Rimonabant—Fatigue—Apraclonidine—glaucoma	0.000537	0.00211	CcSEcCtD
Rimonabant—Headache—Carbachol—glaucoma	0.000535	0.0021	CcSEcCtD
Rimonabant—Infection—Brimonidine—glaucoma	0.000532	0.00209	CcSEcCtD
Rimonabant—Anxiety—Dorzolamide—glaucoma	0.000531	0.00209	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—OPN4—glaucoma	0.000531	0.00683	CbGpPWpGaD
Rimonabant—Anxiety—Travoprost—glaucoma	0.000529	0.00208	CcSEcCtD
Rimonabant—Mood swings—Timolol—glaucoma	0.000529	0.00208	CcSEcCtD
Rimonabant—Nausea—Carteolol—glaucoma	0.000529	0.00208	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000527	0.00207	CcSEcCtD
Rimonabant—Headache—Levobunolol—glaucoma	0.000527	0.00207	CcSEcCtD
Rimonabant—Infestation NOS—Betaxolol—glaucoma	0.000526	0.00207	CcSEcCtD
Rimonabant—Infestation—Betaxolol—glaucoma	0.000526	0.00207	CcSEcCtD
Rimonabant—Depression—Betaxolol—glaucoma	0.000525	0.00206	CcSEcCtD
Rimonabant—Nervous system disorder—Brimonidine—glaucoma	0.000525	0.00206	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000522	0.00205	CcSEcCtD
Rimonabant—Dry mouth—Dorzolamide—glaucoma	0.000521	0.00205	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000521	0.00205	CcSEcCtD
Rimonabant—Skin disorder—Brimonidine—glaucoma	0.00052	0.00204	CcSEcCtD
Rimonabant—Nausea—Diclofenamide—glaucoma	0.00052	0.00204	CcSEcCtD
Rimonabant—Dry mouth—Travoprost—glaucoma	0.000519	0.00204	CcSEcCtD
Rimonabant—Dizziness—Latanoprost—glaucoma	0.000516	0.00203	CcSEcCtD
Rimonabant—Dry mouth—Brinzolamide—glaucoma	0.000513	0.00202	CcSEcCtD
Rimonabant—Vomiting—Methazolamide—glaucoma	0.000512	0.00201	CcSEcCtD
Rimonabant—Gastrointestinal pain—Apraclonidine—glaucoma	0.00051	0.002	CcSEcCtD
Rimonabant—Rash—Methazolamide—glaucoma	0.000508	0.002	CcSEcCtD
Rimonabant—Dermatitis—Methazolamide—glaucoma	0.000507	0.00199	CcSEcCtD
Rimonabant—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000507	0.00653	CbGpPWpGaD
Rimonabant—Nausea—Carbachol—glaucoma	0.000507	0.00199	CcSEcCtD
Rimonabant—Infection—Travoprost—glaucoma	0.000506	0.00199	CcSEcCtD
Rimonabant—Headache—Methazolamide—glaucoma	0.000505	0.00198	CcSEcCtD
Rimonabant—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000503	0.00647	CbGpPWpGaD
Rimonabant—Anxiety—Pilocarpine—glaucoma	0.000502	0.00197	CcSEcCtD
Rimonabant—Paraesthesia—Acetazolamide—glaucoma	0.000501	0.00197	CcSEcCtD
Rimonabant—Nausea—Levobunolol—glaucoma	0.000499	0.00196	CcSEcCtD
Rimonabant—Infection—Brinzolamide—glaucoma	0.000499	0.00196	CcSEcCtD
Rimonabant—Nervous system disorder—Travoprost—glaucoma	0.000499	0.00196	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NGF—glaucoma	0.000496	0.00638	CbGpPWpGaD
Rimonabant—Skin disorder—Travoprost—glaucoma	0.000494	0.00194	CcSEcCtD
Rimonabant—Hyperhidrosis—Dorzolamide—glaucoma	0.000494	0.00194	CcSEcCtD
Rimonabant—Sinusitis—Betaxolol—glaucoma	0.000494	0.00194	CcSEcCtD
Rimonabant—Abdominal pain—Apraclonidine—glaucoma	0.000493	0.00194	CcSEcCtD
Rimonabant—Nervous system disorder—Brinzolamide—glaucoma	0.000493	0.00194	CcSEcCtD
Rimonabant—Angiopathy—Clonidine—glaucoma	0.000493	0.00194	CcSEcCtD
Rimonabant—Rash—Latanoprost—glaucoma	0.000492	0.00193	CcSEcCtD
Rimonabant—Dermatitis—Latanoprost—glaucoma	0.000491	0.00193	CcSEcCtD
Rimonabant—Mediastinal disorder—Clonidine—glaucoma	0.000489	0.00192	CcSEcCtD
Rimonabant—Headache—Latanoprost—glaucoma	0.000488	0.00192	CcSEcCtD
Rimonabant—Skin disorder—Brinzolamide—glaucoma	0.000488	0.00192	CcSEcCtD
Rimonabant—Anorexia—Dorzolamide—glaucoma	0.000487	0.00192	CcSEcCtD
Rimonabant—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000486	0.00625	CbGpPWpGaD
Rimonabant—Decreased appetite—Acetazolamide—glaucoma	0.000485	0.00191	CcSEcCtD
Rimonabant—Insomnia—Brimonidine—glaucoma	0.000484	0.0019	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—OPN4—glaucoma	0.000482	0.00621	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000481	0.00189	CcSEcCtD
Rimonabant—Fatigue—Acetazolamide—glaucoma	0.000481	0.00189	CcSEcCtD
Rimonabant—Paraesthesia—Brimonidine—glaucoma	0.000481	0.00189	CcSEcCtD
Rimonabant—Infection—Pilocarpine—glaucoma	0.00048	0.00189	CcSEcCtD
Rimonabant—Nausea—Methazolamide—glaucoma	0.000478	0.00188	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—PTGFR—glaucoma	0.000478	0.00615	CbGpPWpGaD
Rimonabant—Mental disorder—Clonidine—glaucoma	0.000476	0.00187	CcSEcCtD
Rimonabant—Hallucination—Betaxolol—glaucoma	0.00047	0.00185	CcSEcCtD
Rimonabant—Hypoaesthesia—Betaxolol—glaucoma	0.00047	0.00185	CcSEcCtD
Rimonabant—Hyperhidrosis—Pilocarpine—glaucoma	0.000467	0.00184	CcSEcCtD
Rimonabant—Tension—Clonidine—glaucoma	0.000464	0.00182	CcSEcCtD
Rimonabant—Insomnia—Dorzolamide—glaucoma	0.000462	0.00182	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Brimonidine—glaucoma	0.000462	0.00182	CcSEcCtD
Rimonabant—Fatigue—Brimonidine—glaucoma	0.000461	0.00181	CcSEcCtD
Rimonabant—Anorexia—Pilocarpine—glaucoma	0.00046	0.00181	CcSEcCtD
Rimonabant—Nervousness—Clonidine—glaucoma	0.000459	0.0018	CcSEcCtD
Rimonabant—Paraesthesia—Dorzolamide—glaucoma	0.000459	0.0018	CcSEcCtD
Rimonabant—Insomnia—Brinzolamide—glaucoma	0.000454	0.00179	CcSEcCtD
Rimonabant—Muscle spasms—Clonidine—glaucoma	0.000454	0.00179	CcSEcCtD
Rimonabant—Paraesthesia—Brinzolamide—glaucoma	0.000451	0.00177	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Timolol—glaucoma	0.000448	0.00176	CcSEcCtD
Rimonabant—Asthenia—Apraclonidine—glaucoma	0.000447	0.00176	CcSEcCtD
Rimonabant—Decreased appetite—Dorzolamide—glaucoma	0.000444	0.00175	CcSEcCtD
Rimonabant—Tremor—Clonidine—glaucoma	0.000443	0.00174	CcSEcCtD
Rimonabant—Pruritus—Apraclonidine—glaucoma	0.000441	0.00173	CcSEcCtD
Rimonabant—Fatigue—Dorzolamide—glaucoma	0.000441	0.00173	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Travoprost—glaucoma	0.000439	0.00173	CcSEcCtD
Rimonabant—Fatigue—Travoprost—glaucoma	0.000439	0.00172	CcSEcCtD
Rimonabant—Insomnia—Pilocarpine—glaucoma	0.000437	0.00172	CcSEcCtD
Rimonabant—Decreased appetite—Brinzolamide—glaucoma	0.000437	0.00172	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—PTGFR—glaucoma	0.000434	0.00559	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000434	0.00171	CcSEcCtD
Rimonabant—Paraesthesia—Pilocarpine—glaucoma	0.000434	0.0017	CcSEcCtD
Rimonabant—Asthenia—Bimatoprost—glaucoma	0.000434	0.0017	CcSEcCtD
Rimonabant—Fatigue—Brinzolamide—glaucoma	0.000433	0.0017	CcSEcCtD
Rimonabant—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.00043	0.00553	CbGpPWpGaD
Rimonabant—Depression—Timolol—glaucoma	0.000429	0.00169	CcSEcCtD
Rimonabant—Angiopathy—Betaxolol—glaucoma	0.000429	0.00169	CcSEcCtD
Rimonabant—Pruritus—Bimatoprost—glaucoma	0.000428	0.00168	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—SMO—glaucoma	0.000427	0.00549	CbGpPWpGaD
Rimonabant—Diarrhoea—Apraclonidine—glaucoma	0.000427	0.00168	CcSEcCtD
Rimonabant—Mediastinal disorder—Betaxolol—glaucoma	0.000426	0.00167	CcSEcCtD
Rimonabant—Decreased appetite—Pilocarpine—glaucoma	0.00042	0.00165	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dorzolamide—glaucoma	0.000418	0.00164	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000417	0.00164	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—OPN4—glaucoma	0.000417	0.00536	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Travoprost—glaucoma	0.000416	0.00164	CcSEcCtD
Rimonabant—Mental disorder—Betaxolol—glaucoma	0.000414	0.00163	CcSEcCtD
Rimonabant—Dizziness—Apraclonidine—glaucoma	0.000412	0.00162	CcSEcCtD
Rimonabant—Malnutrition—Betaxolol—glaucoma	0.000411	0.00162	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—LRP12—glaucoma	0.000411	0.00529	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—BAD—glaucoma	0.000409	0.00526	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—C3—glaucoma	0.000406	0.00522	CbGpPWpGaD
Rimonabant—Abdominal pain—Dorzolamide—glaucoma	0.000404	0.00159	CcSEcCtD
Rimonabant—Tension—Betaxolol—glaucoma	0.000404	0.00159	CcSEcCtD
Rimonabant—Sinusitis—Timolol—glaucoma	0.000403	0.00159	CcSEcCtD
Rimonabant—Abdominal pain—Travoprost—glaucoma	0.000402	0.00158	CcSEcCtD
Rimonabant—Anxiety—Clonidine—glaucoma	0.000401	0.00158	CcSEcCtD
Rimonabant—Asthenia—Acetazolamide—glaucoma	0.0004	0.00157	CcSEcCtD
Rimonabant—Dizziness—Bimatoprost—glaucoma	0.0004	0.00157	CcSEcCtD
Rimonabant—Nervousness—Betaxolol—glaucoma	0.0004	0.00157	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.0004	0.00157	CcSEcCtD
Rimonabant—Vomiting—Apraclonidine—glaucoma	0.000396	0.00156	CcSEcCtD
Rimonabant—Muscle spasms—Betaxolol—glaucoma	0.000396	0.00155	CcSEcCtD
Rimonabant—Gastrointestinal pain—Pilocarpine—glaucoma	0.000395	0.00155	CcSEcCtD
Rimonabant—Dry mouth—Clonidine—glaucoma	0.000393	0.00155	CcSEcCtD
Rimonabant—Dermatitis—Apraclonidine—glaucoma	0.000393	0.00154	CcSEcCtD
Rimonabant—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000392	0.00504	CbGpPWpGaD
Rimonabant—Headache—Apraclonidine—glaucoma	0.000391	0.00154	CcSEcCtD
Rimonabant—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000389	0.005	CbGpPWpGaD
Rimonabant—Tremor—Betaxolol—glaucoma	0.000385	0.00152	CcSEcCtD
Rimonabant—Hallucination—Timolol—glaucoma	0.000384	0.00151	CcSEcCtD
Rimonabant—Asthenia—Brimonidine—glaucoma	0.000384	0.00151	CcSEcCtD
Rimonabant—Infection—Clonidine—glaucoma	0.000383	0.00151	CcSEcCtD
Rimonabant—Abdominal pain—Pilocarpine—glaucoma	0.000382	0.0015	CcSEcCtD
Rimonabant—Diarrhoea—Acetazolamide—glaucoma	0.000382	0.0015	CcSEcCtD
Rimonabant—Rash—Bimatoprost—glaucoma	0.000381	0.0015	CcSEcCtD
Rimonabant—Dermatitis—Bimatoprost—glaucoma	0.000381	0.0015	CcSEcCtD
Rimonabant—Connective tissue disorder—Timolol—glaucoma	0.000379	0.00149	CcSEcCtD
Rimonabant—Pruritus—Brimonidine—glaucoma	0.000379	0.00149	CcSEcCtD
Rimonabant—Headache—Bimatoprost—glaucoma	0.000379	0.00149	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—OPN4—glaucoma	0.000378	0.00487	CbGpPWpGaD
Rimonabant—Nervous system disorder—Clonidine—glaucoma	0.000378	0.00149	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—PTGFR—glaucoma	0.000375	0.00483	CbGpPWpGaD
Rimonabant—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000375	0.00483	CbGpPWpGaD
Rimonabant—Skin disorder—Clonidine—glaucoma	0.000375	0.00147	CcSEcCtD
Rimonabant—Hyperhidrosis—Clonidine—glaucoma	0.000373	0.00147	CcSEcCtD
Rimonabant—Nausea—Apraclonidine—glaucoma	0.00037	0.00146	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000369	0.00475	CbGpPWpGaD
Rimonabant—Dizziness—Acetazolamide—glaucoma	0.000369	0.00145	CcSEcCtD
Rimonabant—Anorexia—Clonidine—glaucoma	0.000368	0.00145	CcSEcCtD
Rimonabant—Asthenia—Dorzolamide—glaucoma	0.000367	0.00144	CcSEcCtD
Rimonabant—Asthenia—Travoprost—glaucoma	0.000365	0.00144	CcSEcCtD
Rimonabant—Pruritus—Dorzolamide—glaucoma	0.000362	0.00142	CcSEcCtD
Rimonabant—Asthenia—Brinzolamide—glaucoma	0.000361	0.00142	CcSEcCtD
Rimonabant—Pruritus—Travoprost—glaucoma	0.00036	0.00142	CcSEcCtD
Rimonabant—Nausea—Bimatoprost—glaucoma	0.000359	0.00141	CcSEcCtD
Rimonabant—Pruritus—Brinzolamide—glaucoma	0.000355	0.0014	CcSEcCtD
Rimonabant—Vomiting—Acetazolamide—glaucoma	0.000355	0.00139	CcSEcCtD
Rimonabant—Dizziness—Brimonidine—glaucoma	0.000354	0.00139	CcSEcCtD
Rimonabant—Angiopathy—Timolol—glaucoma	0.00035	0.00138	CcSEcCtD
Rimonabant—Diarrhoea—Dorzolamide—glaucoma	0.00035	0.00137	CcSEcCtD
Rimonabant—Headache—Acetazolamide—glaucoma	0.000349	0.00137	CcSEcCtD
Rimonabant—Anxiety—Betaxolol—glaucoma	0.000349	0.00137	CcSEcCtD
Rimonabant—Insomnia—Clonidine—glaucoma	0.000349	0.00137	CcSEcCtD
Rimonabant—Diarrhoea—Travoprost—glaucoma	0.000348	0.00137	CcSEcCtD
Rimonabant—Mediastinal disorder—Timolol—glaucoma	0.000348	0.00137	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000348	0.00137	CcSEcCtD
Rimonabant—Asthenia—Pilocarpine—glaucoma	0.000346	0.00136	CcSEcCtD
Rimonabant—Paraesthesia—Clonidine—glaucoma	0.000346	0.00136	CcSEcCtD
Rimonabant—Diarrhoea—Brinzolamide—glaucoma	0.000344	0.00135	CcSEcCtD
Rimonabant—Dry mouth—Betaxolol—glaucoma	0.000343	0.00135	CcSEcCtD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000342	0.0044	CbGpPWpGaD
Rimonabant—Pruritus—Pilocarpine—glaucoma	0.000342	0.00134	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—PTGFR—glaucoma	0.000341	0.00438	CbGpPWpGaD
Rimonabant—Mental disorder—Timolol—glaucoma	0.000338	0.00133	CcSEcCtD
Rimonabant—Dizziness—Dorzolamide—glaucoma	0.000338	0.00133	CcSEcCtD
Rimonabant—Rash—Brimonidine—glaucoma	0.000337	0.00133	CcSEcCtD
Rimonabant—Dermatitis—Brimonidine—glaucoma	0.000337	0.00133	CcSEcCtD
Rimonabant—Dizziness—Travoprost—glaucoma	0.000337	0.00132	CcSEcCtD
Rimonabant—Malnutrition—Timolol—glaucoma	0.000336	0.00132	CcSEcCtD
Rimonabant—Headache—Brimonidine—glaucoma	0.000335	0.00132	CcSEcCtD
Rimonabant—Decreased appetite—Clonidine—glaucoma	0.000335	0.00132	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—SMO—glaucoma	0.000335	0.00431	CbGpPWpGaD
Rimonabant—Infection—Betaxolol—glaucoma	0.000334	0.00131	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Clonidine—glaucoma	0.000333	0.00131	CcSEcCtD
Rimonabant—Fatigue—Clonidine—glaucoma	0.000333	0.00131	CcSEcCtD
Rimonabant—Dizziness—Brinzolamide—glaucoma	0.000332	0.00131	CcSEcCtD
Rimonabant—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000332	0.00427	CbGpPWpGaD
Rimonabant—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000332	0.00427	CbGpPWpGaD
Rimonabant—Nausea—Acetazolamide—glaucoma	0.000331	0.0013	CcSEcCtD
Rimonabant—Diarrhoea—Pilocarpine—glaucoma	0.00033	0.0013	CcSEcCtD
Rimonabant—Tension—Timolol—glaucoma	0.00033	0.0013	CcSEcCtD
Rimonabant—Nervous system disorder—Betaxolol—glaucoma	0.000329	0.00129	CcSEcCtD
Rimonabant—Nervousness—Timolol—glaucoma	0.000326	0.00128	CcSEcCtD
Rimonabant—Skin disorder—Betaxolol—glaucoma	0.000326	0.00128	CcSEcCtD
Rimonabant—Vomiting—Dorzolamide—glaucoma	0.000325	0.00128	CcSEcCtD
Rimonabant—Hyperhidrosis—Betaxolol—glaucoma	0.000325	0.00128	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000323	0.00415	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—LRP12—glaucoma	0.000323	0.00415	CbGpPWpGaD
Rimonabant—Rash—Dorzolamide—glaucoma	0.000322	0.00127	CcSEcCtD
Rimonabant—Dermatitis—Dorzolamide—glaucoma	0.000322	0.00127	CcSEcCtD
Rimonabant—Rash—Travoprost—glaucoma	0.000321	0.00126	CcSEcCtD
Rimonabant—Dermatitis—Travoprost—glaucoma	0.000321	0.00126	CcSEcCtD
Rimonabant—Headache—Dorzolamide—glaucoma	0.00032	0.00126	CcSEcCtD
Rimonabant—Anorexia—Betaxolol—glaucoma	0.00032	0.00126	CcSEcCtD
Rimonabant—Vomiting—Brinzolamide—glaucoma	0.000319	0.00126	CcSEcCtD
Rimonabant—Dizziness—Pilocarpine—glaucoma	0.000319	0.00126	CcSEcCtD
Rimonabant—Headache—Travoprost—glaucoma	0.000319	0.00125	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—C3—glaucoma	0.000318	0.0041	CbGpPWpGaD
Rimonabant—Nausea—Brimonidine—glaucoma	0.000318	0.00125	CcSEcCtD
Rimonabant—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000317	0.00408	CbGpPWpGaD
Rimonabant—Rash—Brinzolamide—glaucoma	0.000317	0.00125	CcSEcCtD
Rimonabant—Dermatitis—Brinzolamide—glaucoma	0.000317	0.00124	CcSEcCtD
Rimonabant—Gastrointestinal pain—Clonidine—glaucoma	0.000315	0.00124	CcSEcCtD
Rimonabant—Headache—Brinzolamide—glaucoma	0.000315	0.00124	CcSEcCtD
Rimonabant—Vomiting—Pilocarpine—glaucoma	0.000307	0.00121	CcSEcCtD
Rimonabant—Abdominal pain—Clonidine—glaucoma	0.000305	0.0012	CcSEcCtD
Rimonabant—Rash—Pilocarpine—glaucoma	0.000305	0.0012	CcSEcCtD
Rimonabant—Dermatitis—Pilocarpine—glaucoma	0.000304	0.0012	CcSEcCtD
Rimonabant—Insomnia—Betaxolol—glaucoma	0.000304	0.00119	CcSEcCtD
Rimonabant—Nausea—Dorzolamide—glaucoma	0.000304	0.00119	CcSEcCtD
Rimonabant—Headache—Pilocarpine—glaucoma	0.000303	0.00119	CcSEcCtD
Rimonabant—Nausea—Travoprost—glaucoma	0.000302	0.00119	CcSEcCtD
Rimonabant—Paraesthesia—Betaxolol—glaucoma	0.000301	0.00119	CcSEcCtD
Rimonabant—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.0003	0.00386	CbGpPWpGaD
Rimonabant—Nausea—Brinzolamide—glaucoma	0.000298	0.00117	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000292	0.00376	CbGpPWpGaD
Rimonabant—Decreased appetite—Betaxolol—glaucoma	0.000292	0.00115	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Betaxolol—glaucoma	0.00029	0.00114	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00029	0.00373	CbGpPWpGaD
Rimonabant—Fatigue—Betaxolol—glaucoma	0.000289	0.00114	CcSEcCtD
Rimonabant—Nausea—Pilocarpine—glaucoma	0.000287	0.00113	CcSEcCtD
Rimonabant—Anxiety—Timolol—glaucoma	0.000285	0.00112	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—OPN4—glaucoma	0.000285	0.00367	CbGpPWpGaD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000284	0.00112	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—EDN1—glaucoma	0.000281	0.00362	CbGpPWpGaD
Rimonabant—Dry mouth—Timolol—glaucoma	0.00028	0.0011	CcSEcCtD
Rimonabant—Asthenia—Clonidine—glaucoma	0.000277	0.00109	CcSEcCtD
Rimonabant—Pruritus—Clonidine—glaucoma	0.000273	0.00107	CcSEcCtD
Rimonabant—Infection—Timolol—glaucoma	0.000273	0.00107	CcSEcCtD
Rimonabant—Nervous system disorder—Timolol—glaucoma	0.000269	0.00106	CcSEcCtD
Rimonabant—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000268	0.00345	CbGpPWpGaD
Rimonabant—Skin disorder—Timolol—glaucoma	0.000266	0.00105	CcSEcCtD
Rimonabant—Hyperhidrosis—Timolol—glaucoma	0.000265	0.00104	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—HEYL—glaucoma	0.000265	0.00341	CbGpPWpGaD
Rimonabant—Diarrhoea—Clonidine—glaucoma	0.000264	0.00104	CcSEcCtD
Rimonabant—Anorexia—Timolol—glaucoma	0.000261	0.00103	CcSEcCtD
Rimonabant—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000258	0.00332	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTGFR—glaucoma	0.000257	0.0033	CbGpPWpGaD
Rimonabant—Dizziness—Clonidine—glaucoma	0.000255	0.001	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000253	0.00326	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000251	0.00323	CbGpPWpGaD
Rimonabant—Insomnia—Timolol—glaucoma	0.000248	0.000975	CcSEcCtD
Rimonabant—Paraesthesia—Timolol—glaucoma	0.000246	0.000968	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—C3—glaucoma	0.000246	0.00316	CbGpPWpGaD
Rimonabant—Vomiting—Clonidine—glaucoma	0.000245	0.000964	CcSEcCtD
Rimonabant—Rash—Clonidine—glaucoma	0.000243	0.000956	CcSEcCtD
Rimonabant—Dermatitis—Clonidine—glaucoma	0.000243	0.000955	CcSEcCtD
Rimonabant—Headache—Clonidine—glaucoma	0.000242	0.00095	CcSEcCtD
Rimonabant—Asthenia—Betaxolol—glaucoma	0.000241	0.000947	CcSEcCtD
Rimonabant—Decreased appetite—Timolol—glaucoma	0.000238	0.000937	CcSEcCtD
Rimonabant—Pruritus—Betaxolol—glaucoma	0.000238	0.000934	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Timolol—glaucoma	0.000237	0.000931	CcSEcCtD
Rimonabant—Fatigue—Timolol—glaucoma	0.000236	0.00093	CcSEcCtD
Rimonabant—Diarrhoea—Betaxolol—glaucoma	0.00023	0.000903	CcSEcCtD
Rimonabant—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000229	0.00295	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000229	0.00295	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000229	0.00295	CbGpPWpGaD
Rimonabant—Nausea—Clonidine—glaucoma	0.000229	0.000901	CcSEcCtD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000226	0.0029	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Timolol—glaucoma	0.000224	0.000882	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—OPN4—glaucoma	0.000224	0.00288	CbGpPWpGaD
Rimonabant—Dizziness—Betaxolol—glaucoma	0.000222	0.000873	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—EDN1—glaucoma	0.000221	0.00284	CbGpPWpGaD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000219	0.00282	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—SMO—glaucoma	0.000219	0.00282	CbGpPWpGaD
Rimonabant—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000218	0.00281	CbGpPWpGaD
Rimonabant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000217	0.00279	CbGpPWpGaD
Rimonabant—Abdominal pain—Timolol—glaucoma	0.000217	0.000852	CcSEcCtD
Rimonabant—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000216	0.00278	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000215	0.00276	CbGpPWpGaD
Rimonabant—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000214	0.00276	CbGpPWpGaD
Rimonabant—Vomiting—Betaxolol—glaucoma	0.000213	0.000839	CcSEcCtD
Rimonabant—Rash—Betaxolol—glaucoma	0.000212	0.000832	CcSEcCtD
Rimonabant—Dermatitis—Betaxolol—glaucoma	0.000212	0.000831	CcSEcCtD
Rimonabant—Headache—Betaxolol—glaucoma	0.00021	0.000827	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—HEYL—glaucoma	0.000208	0.00267	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTGFR—glaucoma	0.000201	0.00259	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RPTOR—glaucoma	0.000201	0.00258	CbGpPWpGaD
Rimonabant—Nausea—Betaxolol—glaucoma	0.000199	0.000784	CcSEcCtD
Rimonabant—Asthenia—Timolol—glaucoma	0.000197	0.000774	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—NCK2—glaucoma	0.000194	0.0025	CbGpPWpGaD
Rimonabant—Pruritus—Timolol—glaucoma	0.000194	0.000763	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—C3—glaucoma	0.000193	0.00248	CbGpPWpGaD
Rimonabant—Diarrhoea—Timolol—glaucoma	0.000188	0.000738	CcSEcCtD
Rimonabant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000186	0.00239	CbGpPWpGaD
Rimonabant—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000183	0.00236	CbGpPWpGaD
Rimonabant—Dizziness—Timolol—glaucoma	0.000181	0.000713	CcSEcCtD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000178	0.00228	CbGpPWpGaD
Rimonabant—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000177	0.00228	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000176	0.00226	CbGpPWpGaD
Rimonabant—Vomiting—Timolol—glaucoma	0.000174	0.000686	CcSEcCtD
Rimonabant—Rash—Timolol—glaucoma	0.000173	0.00068	CcSEcCtD
Rimonabant—Dermatitis—Timolol—glaucoma	0.000173	0.000679	CcSEcCtD
Rimonabant—Headache—Timolol—glaucoma	0.000172	0.000676	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—SMO—glaucoma	0.000172	0.00221	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000171	0.00221	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HDAC9—glaucoma	0.000165	0.00213	CbGpPWpGaD
Rimonabant—Nausea—Timolol—glaucoma	0.000163	0.00064	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—EDN1—glaucoma	0.000159	0.00205	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RPTOR—glaucoma	0.000158	0.00203	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NCK2—glaucoma	0.000153	0.00196	CbGpPWpGaD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00015	0.00194	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EDN1—glaucoma	0.000144	0.00186	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000143	0.00184	CbGpPWpGaD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000141	0.00182	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—C3—glaucoma	0.000139	0.00179	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HDAC9—glaucoma	0.00013	0.00167	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SMO—glaucoma	0.000129	0.00166	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—C3—glaucoma	0.000126	0.00162	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—EDN1—glaucoma	0.000125	0.0016	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTT1—glaucoma	0.000118	0.00152	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NTRK2—glaucoma	0.000118	0.00152	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000117	0.00151	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000116	0.00149	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EDN1—glaucoma	0.000113	0.00146	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000113	0.00146	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000109	0.0014	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—C3—glaucoma	0.000109	0.0014	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000103	0.00133	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NGFR—glaucoma	0.000101	0.00131	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SMO—glaucoma	0.000101	0.00131	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.0001	0.00129	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—C3—glaucoma	9.9e-05	0.00127	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	9.8e-05	0.00126	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	9.8e-05	0.00126	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	9.67e-05	0.00124	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NTRK1—glaucoma	9.64e-05	0.00124	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP1B1—glaucoma	9.43e-05	0.00121	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP1B1—glaucoma	9.35e-05	0.0012	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	9.3e-05	0.0012	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NTRK2—glaucoma	9.28e-05	0.00119	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	9.22e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CDKN2B—glaucoma	8.89e-05	0.00114	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.73e-05	0.00112	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EDN1—glaucoma	8.53e-05	0.0011	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA5A—glaucoma	8.3e-05	0.00107	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NARFL—glaucoma	8.3e-05	0.00107	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NARFL—glaucoma	8.22e-05	0.00106	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA5A—glaucoma	8.22e-05	0.00106	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	8.15e-05	0.00105	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP1B1—glaucoma	7.99e-05	0.00103	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NGFR—glaucoma	7.96e-05	0.00102	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	7.88e-05	0.00101	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NGF—glaucoma	7.84e-05	0.00101	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.74e-05	0.000996	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NTRK1—glaucoma	7.57e-05	0.000974	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTM1—glaucoma	7.54e-05	0.00097	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTM1—glaucoma	7.47e-05	0.000962	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.46e-05	0.00096	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—C3—glaucoma	7.45e-05	0.000959	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	7.44e-05	0.000957	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	7.37e-05	0.000949	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA5A—glaucoma	7.03e-05	0.000904	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NARFL—glaucoma	7.03e-05	0.000904	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	6.98e-05	0.000898	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	6.98e-05	0.000898	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN2B—glaucoma	6.97e-05	0.000897	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APOE—glaucoma	6.94e-05	0.000892	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CAV1—glaucoma	6.87e-05	0.000884	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EDN1—glaucoma	6.69e-05	0.000861	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FN1—glaucoma	6.54e-05	0.000842	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—BAD—glaucoma	6.46e-05	0.000832	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTM1—glaucoma	6.39e-05	0.000822	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	6.3e-05	0.000811	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.17e-05	0.000793	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NGF—glaucoma	6.15e-05	0.000791	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.08e-05	0.000782	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—C3—glaucoma	5.85e-05	0.000752	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APOE—glaucoma	5.44e-05	0.0007	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA5A—glaucoma	5.42e-05	0.000698	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NARFL—glaucoma	5.42e-05	0.000698	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CAV1—glaucoma	5.39e-05	0.000694	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOS3—glaucoma	5.2e-05	0.000669	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FN1—glaucoma	5.13e-05	0.00066	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—BAD—glaucoma	5.07e-05	0.000653	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.93e-05	0.000634	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.86e-05	0.000626	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CDKN1B—glaucoma	4.5e-05	0.000579	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—glaucoma	4.17e-05	0.000536	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOS3—glaucoma	4.08e-05	0.000525	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA1—glaucoma	4.05e-05	0.000521	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA1—glaucoma	4.02e-05	0.000517	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CTSA—glaucoma	3.92e-05	0.000505	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CTSA—glaucoma	3.89e-05	0.0005	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—glaucoma	3.74e-05	0.000482	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA2—glaucoma	3.71e-05	0.000477	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA2—glaucoma	3.67e-05	0.000473	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.59e-05	0.000462	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.59e-05	0.000462	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1B—glaucoma	3.53e-05	0.000454	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA1—glaucoma	3.43e-05	0.000442	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CTSA—glaucoma	3.32e-05	0.000428	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—glaucoma	3.27e-05	0.000421	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA2—glaucoma	3.14e-05	0.000404	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.07e-05	0.000395	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.07e-05	0.000395	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—glaucoma	2.94e-05	0.000378	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—glaucoma	2.83e-05	0.000364	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA1—glaucoma	2.65e-05	0.000341	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TXN—glaucoma	2.61e-05	0.000336	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TXN—glaucoma	2.59e-05	0.000333	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CTSA—glaucoma	2.57e-05	0.00033	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA2—glaucoma	2.42e-05	0.000312	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.36e-05	0.000304	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.34e-05	0.000301	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—glaucoma	2.22e-05	0.000286	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TXN—glaucoma	2.21e-05	0.000285	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—glaucoma	2.02e-05	0.00026	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.02e-05	0.00026	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—glaucoma	2.01e-05	0.000258	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2e-05	0.000257	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—glaucoma	1.71e-05	0.000221	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TXN—glaucoma	1.71e-05	0.00022	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.62e-05	0.000208	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCA1—glaucoma	1.61e-05	0.000208	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1B1—glaucoma	1.61e-05	0.000208	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCA1—glaucoma	1.6e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1B1—glaucoma	1.6e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.38e-05	0.000178	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1B1—glaucoma	1.37e-05	0.000176	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCA1—glaucoma	1.37e-05	0.000176	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—glaucoma	1.32e-05	0.00017	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—glaucoma	1.29e-05	0.000166	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—glaucoma	1.28e-05	0.000164	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—glaucoma	1.14e-05	0.000147	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—glaucoma	1.13e-05	0.000145	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—glaucoma	1.09e-05	0.000141	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOE—glaucoma	1.06e-05	0.000136	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1B1—glaucoma	1.05e-05	0.000136	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCA1—glaucoma	1.05e-05	0.000136	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOE—glaucoma	1.05e-05	0.000135	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAV1—glaucoma	1.05e-05	0.000135	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAV1—glaucoma	1.04e-05	0.000134	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—glaucoma	9.65e-06	0.000124	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOE—glaucoma	8.99e-06	0.000116	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAV1—glaucoma	8.9e-06	0.000115	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—glaucoma	8.43e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NOS3—glaucoma	7.95e-06	0.000102	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NOS3—glaucoma	7.88e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—glaucoma	7.45e-06	9.59e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—glaucoma	7.27e-06	9.35e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—glaucoma	7.21e-06	9.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOE—glaucoma	6.94e-06	8.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAV1—glaucoma	6.87e-06	8.84e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NOS3—glaucoma	6.73e-06	8.66e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—glaucoma	6.16e-06	7.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NOS3—glaucoma	5.2e-06	6.69e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—glaucoma	4.75e-06	6.11e-05	CbGpPWpGaD
